| Off-label uses of omalizumab D El-Qutob Clinical reviews in allergy & immunology 50 (1), 84-96, 2016 | 104 | 2016 |
| Sensitization in early age to food allergens in children with atopic dermatitis C Garcia, D El-Qutob, A Martorell, I Febrer, M Rodriguez, JC Cerdá, ... Allergologia et immunopathologia 35 (1), 15-20, 2007 | 79 | 2007 |
| Allergic reaction caused by articaine D El-Qutob, C Morales, A Peláez Allergologia et immunopathologia 33 (2), 115-116, 2005 | 49 | 2005 |
| Hospitalization budget impact during the COVID-19 pandemic in Spain FJ Carrera-Hueso, L Álvarez-Arroyo, JE Poquet-Jornet, ... Health economics review 11, 1-11, 2021 | 35 | 2021 |
| Estudio descriptivo de una cohorte de pacientes con COVID-19 hospitalizados en España L Álvarez-Arroyo, FJ Carrera-Hueso, D El-Qutob, M Robustillo-Villarino, ... Gaceta médica de México 157 (1), 80-87, 2021 | 19 | 2021 |
| Shrimp allergy: beyond avoidance diet. D El-Qutob European annals of allergy and clinical immunology 49 (6), 252-256, 2017 | 17 | 2017 |
| New methods of prevention and treatment of allergic diseases D El-Qutob Lopez Recent Patents on Inflammation & Allergy Drug Discovery 6 (1), 46-64, 2012 | 17 | 2012 |
| Recent advances in immunotherapy for allergic diseases D El-Qutob, G Mencia, E Fernandez-Caldas Recent patents on inflammation & allergy drug discovery 8 (1), 24-35, 2014 | 16 | 2014 |
| New developments in oral vaccines and mucosal adjuvants J L Subiza, D El-Qutob, E Fernandez-Caldas Recent patents on inflammation & allergy drug discovery 9 (1), 4-15, 2015 | 15 | 2015 |
| First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy A Nieto, Á Mazón, M Nieto, E Ibáñez, DT Jang, S Calaforra, P Alba, ... Allergy 77 (10), 3096-3107, 2022 | 11 | 2022 |
| Mammalian raw materials used to produce allergen extracts E Fernández-Caldas, B Cases, D El-Qutob, JF Cantillo Annals of Allergy, Asthma & Immunology 119 (1), 1-8, 2017 | 9 | 2017 |
| Vaccine development and new attempts of treatment for ragweed allergy D El-Qutob Therapeutic Advances in Vaccines 3 (2), 41-47, 2015 | 9 | 2015 |
| Practitioner's Corner DEQ López, BB Zavala, I Ortiz J Investig Allergol Clin Immunol 24 (1), 56-71, 2014 | 8 | 2014 |
| Peptide-based allergen specific immunotherapy for the treatment of allergic disorders D El-Qutob, P Reche, J L Subiza, E Fernández-Caldas Recent Patents on Inflammation & Allergy Drug Discovery 9 (1), 16-22, 2015 | 7 | 2015 |
| High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis D El-Qutob, L Alvarez-Arroyo, I Barreda, M Nieto, M Pin, ... Heart & Lung 53, 77-82, 2022 | 6 | 2022 |
| Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy A Moral, V Moreno, F Girón, D El-Qutob, JD Moure, M Alcántara, A Padial, ... Journal of Asthma and Allergy, 129-133, 2016 | 6 | 2016 |
| Allergic reaction after ingestion of orange blossom pollen DE Lopez, CM Rubio, RC Aznar, AP Hernández Journal of Investigational Allergology and Clinical Immunology 16 (2), 140, 2006 | 6 | 2006 |
| Cancer: Still a contraindication for allergen immunotherapy?: Specific immunotherapy and cancer D El-Qutob, A Letrán, V Matheu, E Fernandez-Caldas World Allergy Organization Journal 14 (10), 100597, 2021 | 5 | 2021 |
| Precision medicine in mite allergic rhinitis R González-Pérez, D El-Qutob, A Letrán, V Matheu Frontiers in Allergy 2, 724727, 2021 | 5 | 2021 |
| Hypothesized epitope localization in hypersensitivity reactions to iodinated contrast media J Borras, D El-Qutob, R Lopez, E Enrique J. investig. allergol. clin. immunol, 82-83, 2019 | 5 | 2019 |
